Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Emerging Infectious Diseases|June 8, 2007
Chikungunya virus in US travelers returning from India, 2006Robert S Lanciotti, Olga L Kosoy, Janeen J Laven, et al.
The Journal of Burn Care & Rehabilitation|November 1, 1995
The 1995 Lindberg Award. Nonthermally mediated muscle injury and necrosis in electrical traumaT A Block, J N Aarsvold, K L Matthews, et al.
The American Journal of Tropical Medicine and Hygiene|April 11, 2022
Duration of West Nile Virus Immunoglobulin M Antibodies up to 81 Months Following West Nile Virus Disease OnsetJ Erin Staples, Katherine B Gibney, Amanda J Panella, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1991
Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cellsR E Dornsife, M H St Clair, A T Huang, et al.
The American Journal of Tropical Medicine and Hygiene|October 31, 2012
Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccinationKatherine B Gibney, Srilatha Edupuganti, Amanda J Panella, et al.
Open Forum Infectious Diseases|June 2, 2020
Investigation of Heartland Virus Disease Throughout the United States, 2013-2017J Erin Staples, Daniel M Pastula, Amanda J Panella, et al.
Cancer Research|May 1, 1992
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trialT J Panella, D C Smith, S C Schold, et al.
Emerging Infectious Diseases|June 21, 2021
Fatal Human Infection with Evidence of Intrahost Variation of Eastern Equine Encephalitis Virus, Alabama, USA, 2019Holly R Hughes, Jason O Velez, Emily H Davis, et al.
Journal of Travel Medicine|October 23, 2018
Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellersNicole P Lindsey, Kalanthe A Horiuchi, Corey Fulton, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neckD M Brizel, K A Leopold, S R Fisher, et al.
Pageof 9